Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Reichmann

Showing results (211-220 of 273) with videos related to

Pageof 28
Sort By:
Journal of Neuroinflammation|June 29, 2016
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studiesT Sehr, U Proschmann, K Thomas, et al.
Fortschritte Der Neurologie-Psychiatrie|August 30, 2013
[Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample]K Rohde, O Riedel, U Lueken, et al.
AJNR. American Journal of Neuroradiology|March 24, 2000
Contrast-enhanced transcranial color-coded duplexsonography in stroke patients with limited bone windowsG Gahn, J Gerber, S Hallmeyer, et al.
Bone Marrow Transplantation|January 26, 2010
CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionD Jing, U Oelschlaegel, R Ordemann, et al.
Biofactors (Oxford, England)|December 30, 2003
Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potentialT Menke, G Gille, F Reber, et al.
Journal of Medical Genetics|May 4, 2004
Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNA(Ile) homoplasmic mutation in the mitochondrial genomeA Limongelli, J Schaefer, S Jackson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2005
Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot studyA Mueller, N D Abolmaali, A R Hakimi, et al.
Neurology|May 29, 2001
Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletionsC Kornblum, R Broicher, E Walther, et al.
Dementia and Geriatric Cognitive Disorders Extra|January 2, 2013
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving TimeO Riedel, A Emmrich, J Klotsche, et al.
European Neurology|February 26, 1998
Follow-up in carriers of the 'MELAS' mutation without strokesM S Damian, A Hertel, P Seibel, et al.
Pageof 28

Showing results (211-220 of 273) with videos related to

Sort By:
Pageof 28
Journal of Neuroinflammation|June 29, 2016
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studiesT Sehr, U Proschmann, K Thomas, et al.
Fortschritte Der Neurologie-Psychiatrie|August 30, 2013
[Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample]K Rohde, O Riedel, U Lueken, et al.
AJNR. American Journal of Neuroradiology|March 24, 2000
Contrast-enhanced transcranial color-coded duplexsonography in stroke patients with limited bone windowsG Gahn, J Gerber, S Hallmeyer, et al.
Bone Marrow Transplantation|January 26, 2010
CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionD Jing, U Oelschlaegel, R Ordemann, et al.
Biofactors (Oxford, England)|December 30, 2003
Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potentialT Menke, G Gille, F Reber, et al.
Journal of Medical Genetics|May 4, 2004
Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNA(Ile) homoplasmic mutation in the mitochondrial genomeA Limongelli, J Schaefer, S Jackson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2005
Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot studyA Mueller, N D Abolmaali, A R Hakimi, et al.
Neurology|May 29, 2001
Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletionsC Kornblum, R Broicher, E Walther, et al.
Dementia and Geriatric Cognitive Disorders Extra|January 2, 2013
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving TimeO Riedel, A Emmrich, J Klotsche, et al.
European Neurology|February 26, 1998
Follow-up in carriers of the 'MELAS' mutation without strokesM S Damian, A Hertel, P Seibel, et al.
Pageof 28